Back to ANIP
VANGUARD GROUP INC ANIP Position History
ANI Pharmaceuticals, Inc.
Quarters held
20
Latest value
$91.4M
Q4 2025
Peak value
$104.5M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $221K |
| Q1 2025 | $418K |
| Q1 2025 | $987K |
| Q1 2025 | $671K |
| Q1 2025 | $76.8M |
| Q2 2025 | $253K |
| Q2 2025 | $407K |
| Q2 2025 | $1.2M |
| Q2 2025 | $654K |
| Q2 2025 | $80.9M |
| Q3 2025 | $613K |
| Q3 2025 | $10.5M |
| Q3 2025 | $355K |
| Q3 2025 | $1.1M |
| Q3 2025 | $104.5M |
| Q4 2025 | $306K |
| Q4 2025 | $634K |
| Q4 2025 | $9.8M |
| Q4 2025 | $927K |
| Q4 2025 | $91.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $91.4M | 1.16M | — | — |
| Q4 2025 | $927K | 11.7K | — | — |
| Q4 2025 | $9.8M | 123.8K | — | — |
| Q4 2025 | $634K | 8.0K | — | — |
| Q4 2025 | $306K | 3.9K | — | — |
| Q3 2025 | $104.5M | 1.14M | — | — |
| Q3 2025 | $1.1M | 11.7K | — | — |
| Q3 2025 | $355K | 3.9K | — | — |
| Q3 2025 | $10.5M | 114.8K | — | — |
| Q3 2025 | $613K | 6.7K | — | — |
| Q2 2025 | $80.9M | 1.24M | — | — |
| Q2 2025 | $654K | 10.0K | — | — |
| Q2 2025 | $1.2M | 17.7K | — | — |
| Q2 2025 | $407K | 6.2K | — | — |
| Q2 2025 | $253K | 3.9K | — | — |
| Q1 2025 | $76.8M | 1.15M | — | — |
| Q1 2025 | $671K | 10.0K | — | — |
| Q1 2025 | $987K | 14.7K | — | — |
| Q1 2025 | $418K | 6.2K | — | — |
| Q1 2025 | $221K | 3.3K | — | — |
Other funds holding ANIP
$123.1M
$118.2M
$98.4M
$68.9M
$68.9M
$65.2M